Cas:346694-73-3 1-benzylpiperidin-3-one,hydrate,hydrochloride manufacturer & supplier

We serve Chemical Name:1-benzylpiperidin-3-one,hydrate,hydrochloride CAS:346694-73-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-benzylpiperidin-3-one,hydrate,hydrochloride

Chemical Name:1-benzylpiperidin-3-one,hydrate,hydrochloride
CAS.NO:346694-73-3
Synonyms:1-Benzyl-3-piperidone hydrochloride hydrate;1-Benzyl-3-piperidone HCl hydrate;1-benzylpiperidin-3-one hydrochloride hydrate;1-benzyl-3-piperidone hcl h2o;1-benzylpiperidin-3-one Hydrate Hydrochloride
Molecular Formula:C12H18ClNO2
Molecular Weight:243.73000
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:29.54000
Exact Mass:243.10300
LogP:2.52710

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-Benzyl-3-piperidone hydrochloride hydrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-benzylpiperidin-3-one Hydrate Hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-benzyl-3-piperidone hcl h2o Use and application,1-benzylpiperidin-3-one Hydrate Hydrochloride technical grade,usp/ep/jp grade.


Related News: According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, 7H-Furo[3,2-g][1]benzopyran-7-one, 3-(aminomethyl)-5-methyl- manufacturers EMA said it considered that the results of the clinical studies used to support the application “were inconsistent and did not satisfactorily show that Nouryant was effective at reducing the ‘off’ time. 1-allyl-3,5-dibutyl-[1,3,5]triazinane-2,4,6-trione suppliers “The approval of Verquvo in the EU will provide doctors, health care professionals and patients with an important treatment option to complement currently available heart failure therapies,” he added. 3-{3-[(R)-2-((E)-3-Hydroxy-oct-1-enyl)-5-oxo-pyrrolidin-1-yl]-propyl}-benzoic acid vendor & factory.